Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Johnson & johnson save search
Biopharma Layoff Tracker 2023: Pfizer, Orna, Kite and More Cut Staff
Published: 2023-12-01 (Crawled : 17:00) - biospace.com/
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: 1.18%
H: 0.0%
C: 0.0%
VXRT | $0.7299 2.08% 0.36% 460K
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
TXMD | $2.74 6.2% -4.75% 18K
|
Health Technology
|
| O: 5.43%
H: 0.0%
C: 0.0%
PTCT | $23.99 4.21% -0.21% 1.1M
|
Health Technology
|
| O: -2.93%
H: 0.0%
C: 0.0%
NKTR | $0.525 7.14% 0.0% 1.1M
|
Health Technology
|
| O: -0.69%
H: 0.0%
C: 0.0%
MOR | $7.01 2.49% -0.57% 2.4M
|
Health Technology
|
| O: -7.16%
H: 0.0%
C: 0.0%
AMRN | $0.75 -4.09% 0.68% 1.7M
|
Health Technology
|
| O: -2.81%
H: 0.0%
C: 0.0%
GOOGL S | $131.86 -0.51% 0.08% 31M
|
Technology Services
|
| O: -2.4%
H: 0.0%
C: 0.0%
GOOG | $133.32 -0.45% 0.14% 24M
|
Technology Services
|
| O: -0.44%
H: 0.0%
C: 0.0%
biopharma
Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of Directors
Published: 2023-12-01 (Crawled : 13:30) - akaritx.com
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: 1.18%
H: 0.0%
C: 0.0%
AKTX | $3.23 9.49% 8.95% 9.3K
|
Health Technology
|
| O: 8.7%
H: 0.0%
C: 0.0%
life sciences therapeutics
Laminar, Inc. Acquired by Johnson & Johnson Medtech for $400 Million Upfront with Additional Clinical and Regulatory Milestone Payments in 2024 and Beyond
Published: 2023-11-30 (Crawled : 23:00) - prnewswire.com
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: 1.18%
H: 0.0%
C: 0.0%
beyond acquired milestone
Samsung Bioepis, J&J Ink Settlement and License Deal for Stelara Biosimilar
Published: 2023-11-30 (Crawled : 20:00) - biospace.com/
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: 0.6%
H: 1.89%
C: 1.58%
biosimilar license deal stelara
Samsung Bioepis, J&J Ink Settlement and License Agreement for Stelara Biosimilar
Published: 2023-11-30 (Crawled : 18:00) - biospace.com/
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: 0.6%
H: 1.89%
C: 1.58%
biosimilar license agreement stelara
Samsung Bioepis, J&J Ink Settlement and License Agreement for Stelara Biosimi...
Published: 2023-11-30 (Crawled : 17:00) - biospace.com/
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: 0.6%
H: 1.89%
C: 1.58%
license agreement stelara
Johnson & Johnson MedTech Acquires Laminar, Inc.
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: 0.6%
H: 1.89%
C: 1.58%
Biopharma Layoff Tracker 2023: Orna, Kite, Candel and More Cut Staff
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: 0.6%
H: 1.89%
C: 1.58%
VXRT | $0.7299 2.08% 0.36% 460K
|
Health Technology
|
| O: -0.46%
H: 6.08%
C: 1.13%
TXMD | $2.74 6.2% -4.75% 18K
|
Health Technology
|
| O: 0.36%
H: 1.43%
C: -7.86%
PTCT | $23.99 4.21% -0.21% 1.1M
|
Health Technology
|
| O: 1.13%
H: 0.0%
C: 0.0%
NKTR | $0.525 7.14% 0.0% 1.1M
|
Health Technology
|
| O: 5.17%
H: 8.7%
C: 6.52%
MOR | $7.01 2.49% -0.57% 2.4M
|
Health Technology
|
| O: 5.04%
H: 9.6%
C: 9.44%
AMRN | $0.75 -4.09% 0.68% 1.7M
|
Health Technology
|
| O: -0.48%
H: 5.84%
C: 4.77%
GOOGL S | $131.86 -0.51% 0.08% 31M
|
Technology Services
|
| O: -1.91%
H: 0.0%
C: 0.0%
GOOG | $133.32 -0.45% 0.14% 24M
|
Technology Services
|
| O: -1.89%
H: 0.41%
C: -1.82%
OCX | $3.88 2.11% 1.68% 7.1K
|
Health Technology
|
| O: -2.37%
H: 0.0%
C: 0.0%
biopharma
Samsung Bioepis Secures US License Date for SB17, a Proposed Biosimilar to Stelara®
Published: 2023-11-30 (Crawled : 08:00) - biospace.com/
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: 0.6%
H: 1.89%
C: 1.58%
sb17 stelara biosimilar license
Arrowhead Pharmaceuticals Reports Fiscal 2023 Year End Results
Published: 2023-11-29 (Crawled : 00:00) - biospace.com/
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ARWR | $23.17 9.29% -1.55% 4.2M
|
Health Technology
|
| O: 0.62%
H: 0.0%
C: 0.0%
year pharmaceuticals results
Pulmonary Arterial Hypertension Market Size Valuation Will Exceed USD 11.35 Billion By 2032, at 5.0% CAGR: Polaris Market Research
Published: 2023-11-29 (Crawled : 15:30) - prnewswire.com
VTRS | $9.37 2.07% 1.92% 6.4M
|
Health Technology
|
| O: 0.11%
H: 0.44%
C: -0.22%
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
UTHR | $240.73 0.3% 0.0% 310K
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: 0.0%
GILD | $77.65 1.37% -0.05% 5.4M
|
Health Technology
|
| O: 0.46%
H: 0.8%
C: 0.51%
research hypertension market
Health and Wellness Market Size Could Reach USD 8,945.30 billion by 2032 | Precedence Research
Published: 2023-11-29 (Crawled : 15:00) - prnewswire.com
UNLYF | $47.86 -0.4% 5.94% 2K
|
Consumer Non-Durables
|
| O: 0.27%
H: 0.0%
C: -0.55%
UL | $47.91 0.44% -0.46% 2.5M
|
Consumer Non-Durables
|
| O: -0.24%
H: 0.18%
C: -0.42%
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
HLF | $13.15 2.1% 0.0% 1.3M
|
Distribution Services
|
| O: -0.04%
H: 0.0%
C: 0.0%
health reach research wellness market
Biopharma Layoff Tracker 2023: Kite, Candel, AbCellera and More Cut Staff
Published: 2023-11-29 (Crawled : 15:00) - biospace.com/
MPSYF | $27.35 7.0% -26.33% 300
|
Health Technology
|
| O: 12.56%
H: 1.41%
C: 1.41%
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
VXRT | $0.7299 2.08% 0.36% 460K
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
TXMD | $2.74 6.2% -4.75% 18K
|
Health Technology
|
| O: -0.7%
H: 5.65%
C: -1.41%
PTCT | $23.99 4.21% -0.21% 1.1M
|
Health Technology
|
| O: 0.96%
H: 6.45%
C: 3.89%
NKTR | $0.525 7.14% 0.0% 1.1M
|
Health Technology
|
| O: 3.48%
H: 0.0%
C: 0.0%
MOR | $7.01 2.49% -0.57% 2.4M
|
Health Technology
|
| O: -0.72%
H: 7.99%
C: 7.99%
AMRN | $0.75 -4.09% 0.68% 1.7M
|
Health Technology
|
| O: -2.39%
H: 3.39%
C: 1.63%
GOOGL S | $131.86 -0.51% 0.08% 31M
|
Technology Services
|
| O: 0.43%
H: 0.0%
C: 0.0%
GOOG | $133.32 -0.45% 0.14% 24M
|
Technology Services
|
| O: 0.3%
H: 0.0%
C: 0.0%
OCX | $3.88 2.11% 1.68% 7.1K
|
Health Technology
|
| O: -0.22%
H: 0.0%
C: -7.32%
biopharma
Bio-Thera Solutions Announces Positive Results from Phase 3 Study of BAT2206, a Proposed Biosimilar Referencing Stelara®
Published: 2023-11-29 (Crawled : 09:00) - prnewswire.com
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
bat2206 stelara biosimilar positive solutions results study
Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®
Published: 2023-11-29 (Crawled : 09:00) - globenewswire.com
ALVO | $9.45 -0.53% -0.42% 180K
|
n/a
|
| O: 0.0%
H: 0.0%
C: -5.05%
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
KMDA | $4.65 -1.69% 0.0% 9.6K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -1.04%
avt05 simponi biosimilar positive results study
FDA Launches Probe of Malignancies Linked to CAR-T Therapies
Published: 2023-11-28 (Crawled : 00:00) - biospace.com/
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: 0.0%
fda car-t
Navigating the Evolving Market Dynamics of Bone Sarcoma: A Comprehensive Analysis of Osteosarcoma, Ewing Sarcoma, and Chondrosarcoma | DelveInsight
Published: 2023-11-28 (Crawled : 22:00) - prnewswire.com
GNLX | $13.33 12.02% 0.0% 200K
|
|
| O: 2.1%
H: 14.7%
C: 9.55%
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
RVMD | $24.5 5.02% -0.53% 1.5M
|
Health Technology
|
| O: 1.45%
H: 3.71%
C: 0.31%
IOVA | $6.26 3.13% -0.48% 6.4M
|
Health Technology
|
| O: 0.72%
H: 5.44%
C: 1.25%
bone market
Metastatic Non-small Cell Lung Cancer Market Forecast Analysis and with Focus on its Immune/Molecular Biomarker Types: PD-L1, EGFR, KRAS, ALK, BRAF, MET, ROS-1, HER2, RET fusion, and NTRK1/2/3 Gene fusion | DelveInsight
Published: 2023-11-28 (Crawled : 22:00) - prnewswire.com
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
LLY 2 d | $584.04 -1.18% 0.34% 3.6M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
SNY | $46.72 -0.06% -0.06% 1.1M
|
Health Technology
|
| O: -0.15%
H: 0.07%
C: -0.66%
BPMC | $72.05 3.46% 0.0% 820K
|
Health Technology
|
| O: 0.5%
H: 1.86%
C: -0.33%
lung biomarker cancer cell market
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides Business Update
Published: 2023-11-28 (Crawled : 21:00) - globenewswire.com
ALVO | $9.45 -0.53% -0.42% 180K
|
n/a
|
| O: 0.0%
H: 0.0%
C: -5.05%
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ABBV | $143.41 0.72% -0.11% 4.9M
|
Health Technology
|
| O: -0.73%
H: 0.78%
C: 0.35%
KMDA | $4.65 -1.69% 0.0% 9.6K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -1.04%
business update financial results
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update
Published: 2023-11-28 (Crawled : 21:00) - globenewswire.com
ALVO | $9.45 -0.53% -0.42% 180K
|
n/a
|
| O: 0.0%
H: 0.0%
C: -5.05%
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ABBV | $143.41 0.72% -0.11% 4.9M
|
Health Technology
|
| O: -0.73%
H: 0.78%
C: 0.35%
KMDA | $4.65 -1.69% 0.0% 9.6K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -1.04%
business update financial results
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
ID 4 | $0.077 -9.41% 25.97% 420K
|
Finance
BKKT 4 | $1.88 25.33% 14.89% 4.8M
|
MGLD | $1.03 7.77% 14K
|
Manufacturing
CZOO | $0.4316 -6.52% 6.7% 65K
|
SATX | $0.4226 -1.72% 6.48% 29K
|
n/a
CCJ | $45.4 -1.13% 4.6% 3.9M
|
Non-Energy Minerals
AUMN | $0.562 0.34% 4.5% 360K
|
Non-Energy Minerals
JBL | $116.91 1.38% 4.3% 2M
|
Electronic Technology
SAIC 4 | $119.92 2.14% 4.24% 460K
|
Technology Services
CULP 4 | $5.06 -0.59% 3.95% 29K
|
Process Industries
Your saved searches
Save your searches and get alerts when important news are released.